Clinical Trial Update: High Dose BAYA1040_Nifedipine: a Dose-comparative Study [Phase 3]

View source ↗

Summary

Phase 3 dose-comparative trial of high-dose BAYA1040_Nifedipine for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BAYA1040_Nifedipine (Nifedipine)

Snippet

Sponsor: Bayer | Conditions: Hypertension | Phase 3 | Status: COMPLETED